92
Participants
Start Date
April 19, 2018
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Tegafur
Tegafur(S-1) 35 mg/m2/b.i.d., day 1 - 7 (maximum dose: 120 mg/day)
Leucovorin
Leucovorin 30 mg/b.i.d., day 1-7
Oxaliplatin
Oxaliplatin 85 mg/m2 in 250 mL of 5% Glucose, given as 2-hour intra- venous infusion, day 1
Gemcitabine
"Gemcitabine 800 mg/m2 in 250 mL of normal saline, given as fixed dose-rate (, 10 mg/m2/min) infusion, day 1; After the administration of gemcitabine, the infusion line should be flushed with 20 ml of normal saline and then 50 ml of 5% glucose solution before the administration of oxaliplatin. in SLOG arm.~Gemcitabine 1000 mg/m2 in 100 mL of normal saline, IV drip for 30 mins on D1 and D8 ,in GC arm"
Cisplatin
Cisplatin 25 mg/m2 in 250ml of normal saline, IV drip for 2 hours on D1 and D8
Taiwan Cooperative Oncology Group, National Health Research Institutes, Taipei
National Health Research Institutes, Taiwan
OTHER